For example, the expression levels of FASN in proliferative non-malignant ovarian epithelial cells and tubal secretory epithelial cells are comparable to that of ovarian cancer cell lines, and inhibitors such as C75 and G28UCM exhibit similar sensitivity against the three cell lines. This evidence concerns the gene FASN and ovarian cancer.